Health Care Providers Understanding of Opioid Analgesic Abuse-Deterrent Formulations: Phase 2 and 3 Surveys

This ICR collects information from healthcare professionals (physicians, PAs, NPs and pharmacists) through two surveys of aimed at obtaining information about their knowledge, attitudes, experiences about abuse-deterrent formulation opioids (ADFs), including related to the ADF terminology. One of the surveys will collect representative data in these areas; the second survey, which will follow the first, will experimentally test the ADF term (the control) against three alternative terms derived, in part, from the general survey to objectively and subjectively determine which term elicits the greatest accuracy in understanding about these products and minimizes knowledge gaps and misperceptions that surfaced in the first qualitative phase of this research as well as in other research. The two surveys described in this ICR make up the second and third phases of a three-phase research project and were informed by the findings obtained from focus groups with healthcare professionals in Phase 1.

The latest form for Health Care Providers Understanding of Opioid Analgesic Abuse-Deterrent Formulations: Phase 2 and 3 Surveys expires 2023-08-31 and can be found here.

Pretest Screener - Phase 2

Federal Enterprise Architecture: Health - Health Care Services